Princeton-led technology for room-temperature vaccines and drugs selected as finalist for Philly-based Science Center research accelerator

Mohammad Seyedsayamdost, a biological chemist investigating the synthesis of novel molecules with therapeutic properties, has been promoted to full professor in the Department of Chemistry. He leads the Seyedsayamdost Group, or “Mo” Lab, a lab under the departments of both chemistry and molecular biology.
Nine exploratory research projects have been selected to receive support from the Dean for Research Innovation Fund, including two environmental research projects that establish new collaborations with industry partners. These research projects are in the early stages of investigation — a time when research funding can be difficult to secure. The collaborations receiving funding are a wastewater treatment project led by Peter Jaffé in partnership with The Chemours Company, and an energy conservation project led by Minjie Chen in partnership with EnaChip Inc.
The Ludwig Princeton Branch, a new branch of the Ludwig Institute for Cancer Research on Princeton’s campus, seeks to fill new research roles investigating cancer metabolism and progression. The roles are Ludwig Princeton Associate Research Scholar and Ludwig Postdoctoral Research Associate at Princeton.
Presented in concert with J.P. Morgan and Johnson & Johnson Innovation on May 18 and 19, the Conference brought together life sciences professionals from 9 countries and 20 states as well as the District of Columbia and featured nearly 70 company and pitch presentations, hundreds of 1:1 partnering meetings and plenary sessions led by industry leaders and world-renowned research institutions from the region.
In the fifth and final episode of “A.I. Nation,” a podcast by Princeton University and Philadelphia public radio station WHYY, computer science professor Ed Felten and WHYY reporter Malcolm Burnley investigate the role of AI in social media and the polarizing effects these algorithms have on us, whether we realize it or not.
AI is being used to combat the COVID-19 pandemic in new and innovative ways, making advancements in healthcare that can be used to curb future pandemics. But at what cost to our privacy?
In the third episode of A.I. Nation, a new podcast by Princeton University and Philadelphia public radio station WHYY, computer science professor Ed Felten and WHYY reporter Malcolm Burnley explore the ways AI has improved our response to the pandemic, particularly in the instrumental advances it has made in solving the protein folding problem.
COVID-19 has been associated with increases in opioid overdose deaths, which may be in part because the pandemic limited access to buprenorphine, a treatment used for opioid dependency, according to a new study led by Princeton University researchers.
Joshua Rabinowitz looks back over a string of collaborations that have led to today's announcement of a new branch of the Ludwig Institute for Cancer Research at Princeton University.